936 Results

People

  1. Tap
    Tap
  2. D'Angelo
    D'Angelo
  3. Gounder
    Gounder
  4. Chi
    Chi
  5. Dickson
    Dickson
  6. Antonescu
    Antonescu
  7. Keohan
    Keohan
  8. Singer
    Singer
  9. Kelly
    Kelly
  10. Qin
    Qin

Groups

  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)
  7. Department of Pathology and Laboratory Medicine (237)
  8. Human Oncology and Pathogenesis Program (232)
  9. Surgery (199)
  10. Sarcoma Surgeons (142)
  1. "Sarcoma Service"
Formats
  1. Journal Article (444)
  2. Meeting Abstract (429)
  3. Review (26)
  4. Editorial (8)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)

More Groups

People
  1. William Tap (372)
  2. Sandra D'Angelo (252)
  3. Mrinal Gounder (228)
  4. Ping Chi (172)
  5. Mark Dickson (169)
  6. Cristina Antonescu (135)

More People

Years
  1. 2025 (27)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (60)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (25)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (286)
  2. American Association for Cancer Research (107)
  3. Oxford University Press (91)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (41)
  6. Springer (40)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Exposure–response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcoma
    Journal Article

    Jones, R. L.; Mo, G.; Baldwin, J. R.; Peterson, P. M.; Ilaria, R. L. Jr; Conti, I.; Cronier, D. M.; Tap, W. D.
    Cancer Chemotherapy and Pharmacology (2019)

    Fulltext@MSK | Save
  • Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Journal Article

    Latham, A.; Srinivasan, P.; Kemel, Y.; Shia, J.; Bandlamudi, C.; Mandelker, D.; Middha, S.; Hechtman, J.; Zehir, A.; Dubard-Gault, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Avelumab immunotherapy: Management of adverse events associated with new treatment for Merkel cell carcinoma
    Journal Article

    Ugolini, H.; Bryan, J.; Hennessy, M.; Kaufman, H. L.; D'Angelo, S. P.
    Clinical Journal of Oncology Nursing (2019)

    Fulltext@MSK | Save
  • Soft tissue sarcoma
    Book Section

    Singer, S.; Tap, W. D.; Kirsch, D. G.; Crago, A. M.
    In DeVita, V. T. Jr; Lawrence, T. S.; Rosenberg, S. A. (Eds.) DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 11th ed (2019)

    Fulltext@MSK | Save
  • Sarcomas of bone in adults
    Book Section

    Gounder, M.; Yamada, Y.; Fabbri, N.
    In The American Cancer Society (Eds.) The American Cancer Society's Oncology in Practice: Clinical Management (2018)

    Fulltext@MSK | Save
  • Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trial
    Journal Article

    Chung, D. J.; Carvajal, R. D.; Postow, M. A.; Sharma, S.; Pronschinske, K. B.; Shyer, J. A.; Singh-Kandah, S.; Dickson, M. A.; D'Angelo, S. P.; Wolchok, J. D.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • Final results of ENLIVEN: A global, double-blind, randomized, placebo-controlled, phase 3 study of pexidartinib in advanced tenosynovial giant cell tumor (TGCT)
    Meeting Abstract

    Tap, W. D.; Gelderblom, H.; Stacchiotti, S.; Palmerini, E.; Ferrari, S.; Desai, J.; Bauer, S.; Blay, J. Y.; Alcindor, T.; Ganjoo, K. N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Mutational analysis and safety/efficacy in a phase 2 multi-center investigation of ABI-009 (nab-rapamycin) in patients with advanced malignant perivascular epithelioid cell tumors (PEComa)
    Meeting Abstract

    Wagner, A. J.; Riedel, R. F.; Van Tine, B. A.; Chugh, R.; Ganjoo, K. N.; Cranmer, L. D.; Pollack, S.; Sankhala, K. K.; Gordon, E. M.; Ravi, V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of PLX9486 alone and in combination (combo) with the KIT inhibitors pexidartinib (pexi) or sunitinib (su) in patients (Pts) with advanced solid tumors and gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Wagner, A. J.; Tap, W. D.; Shields, A. F.; Patnaik, A.; Chugh, R.; Tinoco, G.; Michelson, G.; Alcantar, O.; Pelayo, M.; Zhang, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1b/2 study of olaratumab plus gemcitabine and docetaxel for the treatment of advanced soft tissue sarcoma (STS) (ANNOUNCE 2): Phase 1b results
    Meeting Abstract

    Villalobos, V. M.; Redondo, A.; Van Tine, B. A.; Schwartz, G. K.; Dickson, M. A.; Chmielowski, B.; Peterson, P.; Cronier, D.; Wright, J. A.; Attia, S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save